Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merit Medical Systems (MMSI) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Merit Medical Systems (MMSI) over the last 16 years, with Q3 2025 value amounting to -$24.1 million.

  • Merit Medical Systems' Cash from Investing Activities rose 7919.48% to -$24.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$411.5 million, marking a year-over-year decrease of 15315.32%. This contributed to the annual value of -$368.7 million for FY2024, which is 11024.2% down from last year.
  • As of Q3 2025, Merit Medical Systems' Cash from Investing Activities stood at -$24.1 million, which was up 7919.48% from -$143.4 million recorded in Q2 2025.
  • Merit Medical Systems' 5-year Cash from Investing Activities high stood at -$6.3 million for Q1 2021, and its period low was -$214.4 million during Q4 2024.
  • Moreover, its 5-year median value for Cash from Investing Activities was -$16.5 million (2024), whereas its average is -$44.0 million.
  • Within the past 5 years, the most significant YoY rise in Merit Medical Systems' Cash from Investing Activities was 8846.22% (2024), while the steepest drop was 247038.24% (2024).
  • Over the past 5 years, Merit Medical Systems' Cash from Investing Activities (Quarter) stood at -$14.6 million in 2021, then dropped by 18.63% to -$17.3 million in 2022, then skyrocketed by 51.86% to -$8.3 million in 2023, then plummeted by 2470.38% to -$214.4 million in 2024, then surged by 88.78% to -$24.1 million in 2025.
  • Its Cash from Investing Activities stands at -$24.1 million for Q3 2025, versus -$143.4 million for Q2 2025 and -$29.6 million for Q1 2025.